Share This Article:

Incidence and Clinical Characteristics of Deep Vein Thrombosis (DVT) after Total Knee Arthroplasty (TKA) with DVT Chemoprophylaxis

Abstract Full-Text HTML XML Download Download as PDF (Size:2526KB) PP. 531-538
DOI: 10.4236/wjcd.2014.411064    3,830 Downloads   4,714 Views   Citations


Objective: Deep vein thrombosis (DVT) after total knee arthroplasty (TKA) is very common and leading cause of death due to this procedure. The objective of this study was to investigate the incidence and clinical characteristics of DVT after TKA with DVT chemoprophylaxis. Methods: This is a prospective cohort study in single institution. The patients received postoperative DVT chemoprophylaxis (low molecular weight heparin (LMWH) or Fondaparinux), followed by duplex ultrasonography to check for DVT 1 - 2 weeks after TKA. The clinical characteristics were summarized and analysed by chi-square test and regression analysis. Results: Five hundred and thirty four patients were enrolled from January 2007 to December 2010. DVT chemoprophylaxis was administered in 524 (98.1%) of the 534 patients. DVT occurred in 9 subjects (1.69%); 8 subjects had DVT in the leg, and 1 subject had a pulmonary embolism. Among them, asymptomatic DVT was observed in 5 patients (0.94%). Univariate analysis showed that surgical methods (revision, P = 0.0007), body mass index (BMI) (>25, P = 0.0028), low platelet count (less than 150 × 103, P = 0.0219), time in the intensive care unit (ICU) (P < 0.0001), no administration of prophylactic LMWH (P = 0.0392), and a history of DVT (P < 0.0001) were significant risk factors of DVT. Conclusions: The incidence of DVT was 1.69% after TKA with prophylactic antithrombotic therapy. Revision surgery, BMI, low platelet count, time in ICU, absence of prophylactic LMWH and history of DVT were significant risk factors of DVT.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Won, Y. , Kim, M. , Jun, K. , Nam, W. , Ahn, S. , Hwang, J. , Kim, S. , Park, S. , Yun, S. , Lee, W. , Park, J. and Kim, J. (2014) Incidence and Clinical Characteristics of Deep Vein Thrombosis (DVT) after Total Knee Arthroplasty (TKA) with DVT Chemoprophylaxis. World Journal of Cardiovascular Diseases, 4, 531-538. doi: 10.4236/wjcd.2014.411064.


[1] National Institute for Health and Clinical Excellence (NICE) (2007) Venous Thromboembolism: Reducing the Risk of Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism) in Inpatients Undergoing Surgery. NIGE, London.
[2] Geerts, W.H., Bergqvist, D., Pineo, G.F., et al. (2008) Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 133, 381S-453S.
[3] Guyatt, G.H., Akl, E.A., Crowther, M., et al. (2012) Executive Summary: Antithrombotic Therapy and Prevention of thrombosis. Chest, 141, 7S-47S.
[4] (2007) American Academy of Orthopaedic Surgeons Clinical Guideline on Prevention of Symptomatic Pulmonary Embolism in Patients Undergoing Total Hip or Knee Arthroplasty. Adopted by the American Academy of Orthopedic Surgeons Board of Directors.
[5] Nicolaides, A.N. (2001) Prevention of Venous Thromboembolism. International Consensus Statement. Guidelines Compiled in Accordance with the Scientific Evidence. International Angiology, 20, 1-37.
[6] Goel, D.P., Buckley, R., de Vries, G., et al. (2009) Prophylaxis of Deep-Vein Thrombosis in Fractures below the Knee: A Prospective Randomized Controlled Trial. Journal of Bone and Joint Surgery—British Volume, 91, 388-394.
[7] Johnson, R., Carmichael, J.H., Almond, H.G., et al. (1978) Deep Venous Thrombosis Following Chamley Arthroplasty. Clinical Orthopaedics and Related Research, 132, 24-30.
[8] Kim, Y.H. (1990) The Incidence of Deep Vein Thrombosis after Cementless and Cemented Knee Replacement. Journal of Bone and Joint Surgery—British Volume, 72B, 779-83.
[9] Yoo, M.C., Kang, Y.H., Kim, Y.H., et al. (1997) A Prospective Study on the Use of Nadroparin Calcium in the Prophylaxis of Thromboembolism in Korean Patients Undergoing Total Hip Replacement. International Orthopaedics, 21, 399-402.
[10] Kim, Y.H., Choi, I.Y., Park, M.R., et al. (1997) Deep Vein Thrombosis after Uncemented Total Hip Replacement. Bulletin of the Hospital for Joint Diseases, 56, 133-139.
[11] Moon, K.H., Kim, W.H. and Lee, J.Y. (1998) Deep Vein Thrombosis after Cementless Total Hip Replacement Arthroplasty Using Doppler Ultrasound. Journal of the Korean Orthopaedic Association, 33, 1553-1559.
[12] Song, E.K., Kim, J.K., Lee, K.B. and Seon, J.K. (1998) Deep Vein Thrombosis after Total Knee Replacement. Incidence and Correlation with Clinical Risk Factors. Journal of Korean Knee Society, 10, 18-22.
[13] Kim, Y.H. and Kim, J.S. (2002) Incidence and Natural History of Deep-Vein Thrombosis after Total Knee Arthroplasty: A Prospective, Randomized Study. Journal of Bone and Joint Surgery, 84B, 566-570.
[14] Dhillon, K.S., Askander, A. and Doraismay, S. (1996) Postoperative Deep-Vein Thrombosis in Asian Patients Is Not a Rarity. A Prospective Study of 88 Patients with No Prophylaxis. Journal of Bone and Joint Surgery, 78B, 427-430.
[15] Fujita, S., Hirota, S., Oda, T., Kato, Y., Tsukamoto, Y. and Fuji, T. (2000) Deep Venous Thrombosis after Total Hip or Total Knee Replacement in Japan. Clinical Orthopaedics and Related Research, 375, 168-174.
[16] Wang, C.J., Wang, J.W., Chen, L.M., Chen, H.S., Yang, B.Y. and Cheng, S.M. (2000) Deep Vein Thrombosis after Total Knee Arthroplasty. Journal of the Formosan Medical Association, 99, 848-853.
[17] Fong, Y.K., Ruban, P., Yeo, S.J., Lee, B.P., Lo, N.N., Seow, K.H. and Ng, S.C. (2000) Use of Low Molecular Weight Heparin for Prevention of Deep Vein Thrombosis in Total Knee Arthroplasty. A Study of Its Efficacy in an Asian Population. Annals of the Academy of Medicine, Singapore, 29, 439-441.
[18] Piovella, F., Wang, C.J., Lu, H., Lee, K., Lee, L.H., Lee, W.C., et al. (2005) Deep-Vein Thrombosis Rates after Major Orthopedic Surgery in Asia. An Epidemiological Study Based on Postoperative Screening with Centrally Adjudicated Bilateral Venography. Journal of Thrombosis and Haemostasis, 3, 2664-2670.
[19] Leizorovicz, A., Turpie, A.G.G., Cohen, A.T., Wong, L., Yoo, M.C., Dans, A., et al. (2005) Epidemiology of Venous Thromboembolism in Asian Patients Undergoing Major Orthopedic Surgery without Thromboprophylaxis. The SMART Study. Journal of Thrombosis and Haemostasis, 3, 28-34.
[20] Cha, S.I., Lee, S.Y., Kim, C.H., Park, J.Y., Jung, T.H., Yi, J.H., et al. (2010) Venous Thromboembolism in Korean Patients Undergoing Major Orthopedic Surgery: A Prospective Observational Study Using Computed Tomographic (CT) Pulmonary Angiography and Indirect CT Venography. Journal of Korean Medical Science, 25, 28-34.
[21] US Department of Health and Human Services (2008) The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism.
[22] Cohen, A.T. (2010) Asia-Pacific Thrombosis Advisory Board Consensus Paper on Prevention of Venous Thromboembolism after Major Orthopaedic Surgery. Thrombosis and Haemostasis, 104, 919-930.
[23] Mashio N. (2004) Japanese Guidelines for Prevention of Venous Thromboembolism. Journal of Japan Society for Clinical Anesthesia, 24, 480-487.
[24] Bang, S.M., Jang, M.J., Oh, D., Kim, Y.K., Kim, I.H., Yoon, S.S., et al. (2010) Korean Guidelines for the Prevention of Venous Thromboembolism. Journal of Korean Medical Science, 25, 1553-1559.
[25] Schellong, S.M., Beyer, J., Kakkar, A.K., Halbritter, K., Eriksson, B.I., Turpie, A.G.G., et al. (2007) Ultrasound Screening for Asymptomatic Deep Vein Thrombosis after Major Orthopaedic Surgery: The VENUS Study. Journal of Thrombosis and Haemostasis, 5, 1431-1437.
[26] Barnes, W.R., Nix, M.L., Barnes, C.L., Lavender, R.C., Golden, W.E., Harmon, B.H., et al. (1989) Perioperative Asymptomatic Venous Thrombosis: Role of Duplex Scanning versus Venography. Journal of Vascular Surgery, 9, 251-260.
[27] Quinlan, D.J., Eikelboom, J.W., Dahl, O.E., Eriksson, B.I., Sidhu, P.S. and Hirsh, J. (2007) Association between Asymptomatic Deep Vein Thrombosis Detected by Venography and Symptomatic Venous Thromboembolism in Patients Undergoing Elective Hip or Knee Surgery. Journal of Thrombosis and Haemostasis, 5, 1438-1443.
[28] Xing, K.H., Morrison, G., Lim, W., Douketis, J., Odueyungbo, A. and Crowther, M. (2008) Has the Incidence of Deep Vein Thrombosis in Patients Undergoing Total Hip/Knee Arthroplasty Changed over Time? A Systematic Review of Randomized Controlled Trials. Thrombosis Research, 123, 24-34.
[29] Leizorovicz, A., Haugh, M.C., Chapuis, F.R., Samama, M.M. and Boissel, J.P. (1992) Low Molecular Weight Heparin in Prevention of Perioperative Thrombosis. British Medical Journal, 305, 913-920.
[30] Eikelboom, J.W., Quinlan, D.J. and Douketis, J.D. (2001) Extended-Duration Prophylaxis against Venous Thromboembolism after Total Hip or Knee Replacement: A Meta-Analysis of the Randomised Trials. The Lancet, 358, 9-15.
[31] Kanaan, A.O., Silva, M.A., Donovan, J.L., Roy, T. and Al-Homsi, A.S. (2007) Meta-Analysis of Venous Thromboembolism Prophylaxis in Medically Ill Patients. Clinical Therapeutics, 29, 2395-2405.
[32] Struijk-Mulder, M.C., Ettema, H.B., Verheye, C.C. and Büller, H.R. (2010) Comparing Consensus Guidelines on Thromboprophylaxis in Orthopedic Surgery. Journal of Thrombosis and Haemostasis, 8, 678-683.
[33] Silbersack, Y., Taute, B.M., Hein, W. and Podhaisky, H. (2004) Prevention of Deep-Vein Thrombosis after Total Hip and Knee Replacement: Low Molecular-Weight Heparin in Combination with Intermittent Pneumatic Compression. Journal of Bone and Joint Surgery, 86, 809-812.
[34] Markovic-Denic, L., Zivkovic, K., Lesic, A., Bumbasirevic, V., Dubljanin-Raspopovic, E. and Bumbasirevic, M. (2012) Risk Factors and Distribution of Symptomatic Venous Thromboembolism in Total Hip and Knee Replacements: Prospective Study. International Orthopaedics, 36, 1299-1305.
[35] Cohen, A.T., Tapson, V.F., Bergmann, J.F., Goldhaber, S.Z., Kakkar, A.K. and Deslandes, B. (2008) Venous Thromboembolism Risk and Prophylaxis in the Acute Hospital Care Setting (ENDORSE Study): A Multinational Cross-Sectional Study. The Lancet, 371, 387-394.

comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.